000 | 01926 a2200565 4500 | ||
---|---|---|---|
005 | 20250513204112.0 | ||
264 | 0 | _c20000411 | |
008 | 200004s 0 0 eng d | ||
022 | _a0269-9370 | ||
024 | 7 |
_a10.1097/00002030-200001070-00005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaint-Marc, T | |
245 | 0 | 0 |
_aFat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. _h[electronic resource] |
260 |
_bAIDS (London, England) _cJan 2000 |
||
300 |
_a37-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdiagnostic imaging |
650 | 0 | 4 |
_aAdipose Tissue _xmetabolism |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xanalysis |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 |
_aLipids _xanalysis |
650 | 0 | 4 |
_aLipodystrophy _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aRNA, Viral _xanalysis |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadverse effects |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aPartisani, M | |
700 | 1 | _aPoizot-Martin, I | |
700 | 1 | _aRouviere, O | |
700 | 1 | _aBruno, F | |
700 | 1 | _aAvellaneda, R | |
700 | 1 | _aLang, J M | |
700 | 1 | _aGastaut, J A | |
700 | 1 | _aTouraine, J L | |
773 | 0 |
_tAIDS (London, England) _gvol. 14 _gno. 1 _gp. 37-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200001070-00005 _zAvailable from publisher's website |
999 |
_c10668474 _d10668474 |